Wei Li

Wei Li is currently the Associate Director of New Product Planning Commercial Assessments and Forecasting at Sanofi, where they focus on forecasting for rare and oncology assets. Previously, they served as a Senior Manager of Business Analytics and Insights at Amgen, developing forecasting frameworks for multi-billion dollar oncology portfolios. Earlier in their career, Wei gained experience as a Business Consultant and Associate Consultant at ZS, where they contributed to sales force effectiveness and market research. Wei earned a Ph.D. in Neuroscience from UCLA and a B.S. in Computation and Neural Systems from Caltech.